Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07278544 · ClinicalTrials.gov registry record · NA

Harnessing Communication Preferences

A NA study of Autism Spectrum Disorder and Intellectual Disability, sponsored by Joel E. Ringdahl.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT07278544 is a NA study of Autism Spectrum Disorder and Intellectual Disability that is actively recruiting participants, run by Joel E. Ringdahl. The registered enrollment target is 60 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07278544, a NA study of Autism Spectrum Disorder and Intellectual Disability, is actively recruiting participants, sponsored by Joel E. Ringdahl.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to evaluate how preference for communication approach (e.g., using a touch talker versus picture cards) impacts treatment maintenance in the context of treatment to reduce challenging behavior exhibited by individuals with intellectual and/or developmental disabilities. As well, the clinical trial will evaluate how this preference impacts treatment relapse when care providers implement intervention and will identify potential demographic variables (e.g., age and symptom severity) that affect outcomes. The main question\[s\] it aims to answer \[is/are\]: Preferred communication strategies will persist to a greater extent when intervention is disrupted, relative to less preferred communication strategies. Communication modality preference will increase persistence for individuals with lower pre-experimental symptom severity scores and higher pre-experimental communication functioning scores. We predict demographic characteristics and developmental level will not impact intervention outcomes. Two groups will be compared. Group 1 will receive initial intervention using a preferred communication strategy. Group 2 will receive initial intervention using a non preferred, but effective, communication strategy. Intervention type will then be reversed. Researchers will compare preferred and non preferred interventions on continued expression of the communication strategy when intervention is challenged. Participants will exhibit alternative appropriate communicative behavior as a means of replacing/reducing challenging behavior. This will take place using (a) preferred communication strategies and (b) non preferred communication strategies. Following successful intervention with each type of communication, intervention will be challenged and continued use of the communication strategy will be measured.

Interventions

  • BEHAVIORAL PrefFCT
  • BEHAVIORAL NonPrefFCT

Study Locations (2)

Georgia

  • University of Georgia - Athens

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-15
Est. Completion 2031-03-31
Phase NA

Sponsor

Joel E. Ringdahl

1 total trials

What the Registry Record Tells You About NCT07278544

The ClinicalTrials.gov registry entry for NCT07278544 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The listed sponsor is Joel E. Ringdahl, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which PrefFCT is the first listed.

NCT07278544 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Iowa.

Frequently Asked Questions

What is clinical trial NCT07278544 about?

NCT07278544 is a clinical study titled "Harnessing Communication Preferences". The goal of this clinical trial is to evaluate how preference for communication approach (e.g., using a touch talker versus picture cards) impacts treatment maintenance in the context of treatment to reduce challenging behavior exhibited by individuals with intellectual and/or developmental disabili...

What is the current status of trial NCT07278544?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-15. Estimated completion is 2031-03-31.

What conditions does trial NCT07278544 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Intellectual Disability, Self Injurious Behavior, Communication Disabilities, Communication, Nonverbal.

What interventions are being tested in trial NCT07278544?

The interventions under investigation include: PrefFCT (BEHAVIORAL), NonPrefFCT (BEHAVIORAL).

Who is sponsoring clinical trial NCT07278544?

This trial is sponsored by Joel E. Ringdahl, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07278544 being conducted?

This trial has 2 study locations across Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.